The Latest Cardiac and Vascular News
December 02, 2024 08:00 AM Eastern Standard Time SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the world leader in AI-driven medical imaging analysis and coordinated care, today announced the launch of its Rapid Enterprise™ Platform, powered by Rapid Edge Cloud. Rapid Enterprise includes the addition of the Rapid Navigator Pro™ and third-party integration. […]
Company expands clinical program beyond 70 patients already treated in South America FIH and Feasibility Studies. FDA acknowledged potential benefits of the Supira System by granting the company a review pathway under the Breakthrough Device Program. Results from EFS will be used to support submission to FDA for Supira’s pivotal […]
AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of…
– Solid Biosciences to collaborate with Mayo Clinic’s genetic cardiology disease laboratory –
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases, today announced the completion of a $115 million Series D financing that included the conversion of issued convertible […]
PALO ALTO, Calif.–(BUSINESS WIRE)–Vista, a leader in intelligent MRI acquisition software, today announced two-year clinical results showing Vista Cardiac significantly improves workflow efficiency, ensures high-quality and consistent imaging, and scales cardiac MRI (CMR) programs to expand access to more patients. “We’re pleased with the strong data from Brigham and Women’s Hospital validating […]
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ — Coronary artery calcification (CAC) affects 20 million Americans annually, and over half of the incidental findings go unreported.* New FDA-cleared technology from Riverain can provide a…
December 3, 2024
First Time in the Company’s History REDWOOD CITY, Calif., Dec. 3, 2024 /PRNewswire/ — Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced achieving…
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the way AF is treated. PRAGUE, Dec. 3, 2024…
